secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0001493152-24-036453
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.0, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zyversa Therapeutics enters $1.4M ATM equity offering with A.G.P.
-----------------------------------------------------------------

- Entered ATM Agreement with A.G.P./Alliance Global Partners to sell up to $1,397,396 of common stock.
- Agent receives 3.0% commission; sales at prevailing market prices under effective shelf registration.
- Proceeds to be used for working capital and general corporate purposes, including R&D.
- No minimum offering; Company not obligated to sell any shares under the Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224036453/0001493152-24-036453-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315224036453/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-036453

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer